COMMUNIQUÉS West-GlobeNewswire

SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2018 Financial Results
15/08/2018
NEW YORK, Aug. 15, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]
Avalon GloboCare Provides Second Quarter 2018 Business Update; Reports 32% Increase in Revenues
15/08/2018
FREEHOLD, N.J., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, today announced financial results and provided a business update for the [...]
BioCorRx Provides Business Update for the Second Quarter of 2018
15/08/2018
ANAHEIM, CA, Aug. 15, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update [...]
Delcath Announces Second Quarter Fiscal 2018 Financial Results
15/08/2018
NEW YORK, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces financial results for the [...]
William Demant Holding A/S: Managers' transactions
15/08/2018
Company announcement no 2018-09 15 August 2018 Report on transactions with William Demant Holding A/S shares by senior executives and closely related parties Notification on transactions with William Demant Holding A/S [...]
Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort
15/08/2018
PHILADELPHIA and OXFORD, United Kingdom, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced a favorable review of safety data from [...]
Innovate Biopharmaceuticals Reports Second Quarter 2018 Earnings and Key Corporate Highlights
15/08/2018
Added as a member of the broad-market Russell 3000®, 2000® and Microcap® Indexes Innovate plans to host a Clinical and Scientific Update on September 6, 2018, in New York City Multiple research collaborations with [...]
Aptose Announces Appointment of Carol Ashe to Board of Directors
15/08/2018
SAN DIEGO and TORONTO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of [...]
Bio-Path Holdings Reports Second Quarter 2018 Financial Results
15/08/2018
Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi [...]
ProQR to Present Interim Phase 1/2 Results for QR-110 in Leber’s Congenital Amaurosis 10 at the Symposium for Retinal Degeneration on Sept. 5th
15/08/2018
Presentation at the 18th International Symposium on Retinal Degeneration (RD2018) at 8:30 am GMT on Sept. 5th Investor conference call to be held at 8:15 am ET on Sept. 5th LEIDEN, The Netherlands and CAMBRIDGE, Mass., [...]
EyePoint Pharmaceuticals Appoints John Weet, Ph.D., as SVP, Regulatory Affairs & Quality
15/08/2018
- Senior Pharmaceutical Industry Executive with Extensive Experience Leading Regulatory Affairs - WATERTOWN, Mass., Aug. 15, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty [...]
International Stem Cell Corporation Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018
15/08/2018
CARLSBAD, Calif., Aug. 15, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
Verrica Appoints Neetu Dhaliwal as Vice President of Business Development
15/08/2018
WEST CHESTER, Pa., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical [...]
Auris Medical Reports Second Quarter 2018 Financial Results and Provides Business Update
15/08/2018
Dosing in second Phase 1 clinical trial with intranasal betahistine nearing completion Approaching important interactions with regulatory agencies Progressing with strategic repositioning of Company Zug, Switzerland, [...]
Mundipharma brings its cancer supportive care expertise to Vietnam after signing agreement with Helsinn Group for ALOXI® (palonosetron HCl)
15/08/2018
Mundipharma brings its cancer supportive care expertise to Vietnam after signing agreement with Helsinn Group for ALOXI ® (palonosetron HCl) Mundipharma and Helsinn Group expand exclusive licensing and distribution [...]
Aegis is Awarded US Patent for Formulation and Non-invasive Delivery of Peptide Drugs
15/08/2018
Aegis' Intravail® technology provides stable formulations of cyclic peptides for non-invasive delivery and reduced immunogenicity SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that [...]
PotNetwork Holdings, Inc. Reports 6-Month Revenues of over $12 Million, or More than Two Times its Revenues for the Same Period in 2017
15/08/2018
FT. LAUDERDALE, Fla., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Company Posts Financial Results for First Half of 2018 via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink: POTN ) announced today that the Company’s six month [...]
RavenQuest Signs Services Contract With Alexander First Nation
15/08/2018
VANCOUVER, British Columbia, Aug. 15, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) is pleased to announce it has entered into a services [...]
HealthLynked Corp. Reports Second Quarter 2018 Results, including 10% Revenue Growth in the Second Quarter of 2018
15/08/2018
NAPLES, Fla., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Naples, FL August 15, 2018 – HealthLynked Corp. (OTCQB: HLYK ), late yesterday reported its results for the second quarter of 2018. Second Quarter 2018 Highlights: 10% [...]

Pages